Fry Donald E
Department of Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Am Surg. 2012 Jan;78(1):1-8.
Human sepsis is thought to be systemic inflammatory response syndrome (SIRS) that is activated by invasive infection. The multiple organ dysfunction syndrome (MODS) is the identified failure of critical organ function in patients that have sustained SIRS. Because SIRS and MODS are consequences of the excessive activation of inflammation, extensive research and numerous clinical trials have pursued treatments that would modify the inflammatory response. This presentation reviews the normal local mechanisms of inflammation and provides a theoretical framework for the transition of the inflammatory process to a systemic level. Clinical trials with biomodulators to block or inhibit inflammation have generally failed to improve the outcomes in patients with severe sepsis, septic shock, and MODS. The role of counter-inflammatory signaling and the newer concept of the cholinergic anti-inflammatory pathway are being investigated, and newer hypotheses are focusing upon the balancing of proinflammatory and counter-inflammatory mechanisms as important directions for newer therapies. It is concluded that failure to define novel and effective treatments reflects fundamental gaps in our understanding of inflammation and its regulation.
人类脓毒症被认为是由侵袭性感染激活的全身炎症反应综合征(SIRS)。多器官功能障碍综合征(MODS)是已发生SIRS的患者中出现的关键器官功能衰竭。由于SIRS和MODS是炎症过度激活的后果,因此广泛的研究和大量临床试验一直在探索能够调节炎症反应的治疗方法。本报告回顾了炎症的正常局部机制,并为炎症过程向全身水平的转变提供了理论框架。使用生物调节剂阻断或抑制炎症的临床试验通常未能改善严重脓毒症、感染性休克和MODS患者的预后。抗炎信号传导的作用以及胆碱能抗炎途径的新概念正在研究中,新的假说将促炎和抗炎机制的平衡作为新治疗方法的重要方向。得出的结论是,未能确定新颖有效的治疗方法反映出我们对炎症及其调节的理解存在根本性差距。